[Immunogenicity and safety of vaccine preparations based on circulating Bordetella pertussis strains].
Zh Mikrobiol Epidemiol Immunobiol
; (4): 18-22, 2014.
Article
in Ru
| MEDLINE
| ID: mdl-25286523
ABSTRACT
AIM:
Study specific activity and safety ofvaccine preparations based on circulating B. pertussis strains with currently predominating allele variants of pertussis toxin (ptxA1) and pertactin (prn2) genes. MATERIALS ANDMETHODS:
B. pertussis strains isolated from pertussis patients in Moscow in 2001-2010 were grown in dense and liquid media. The content of separate antigens in B. pertussis strains was determined by EIA. Immunogenicity and safety of the preparations was determined in F1(CBAxC57B16) line mice.RESULTS:
All the studied circulating B. pertussis strains expressed pertussis toxin (PT), filamentous hemagglutinin (FHA) and agglutinogens corresponding to the serovar. Whole-cell and acellular pertussis vaccines were prepared based on the circulating strains, and a highly productive recently isolated toxigenic B.pertussis strain that could be used for production ofpertussis vaccines was selected as a result of studies ofimmunogenic, toxic and sensibilizing properties.CONCLUSION:
Vaccine preparations based on a B. pertussis strain adapted to growth in liquid media with pertussis toxin and pertactin ptxAl1 - prn2 gene allele variation characteristic for contemporary population are specifically active and safe.
Search on Google
Database:
MEDLINE
Main subject:
Bordetella pertussis
/
Pertussis Vaccine
/
Whooping Cough
Limits:
Animals
/
Humans
Country/Region as subject:
Europa
Language:
Ru
Year:
2014
Type:
Article